Anticancer effects of four ruthenium-cyclopentadienyl compounds in colorectal cancer cells: proteomic data

Name: Anticancer effects of four ruthenium-cyclopentadienyl compounds in colorectal cancer cells: proteomic data
Creator: Ana Rita Brás
Published: 2023-05-05T03:29:09.673Z
Keywords: Proteomics

Brás, Ana Rita; Fernandes, Pedro; Moreira, Tiago; Morales-Sanfrutos, Julia; Sabidó, Eduard; M.M. Antunes, Alexandra; Valente, Andreia; Preto, Ana

doi:10.17632/sm47g26jv4.1

Anticancer effects of four ruthenium-cyclopentadienyl compounds in colorectal cancer cells: proteomic data

Published: 5 May 2023| Version 1 | DOI: 10.17632/sm47g26jv4.1

Contributors:

Ana Rita Brás, Pedro Fernandes, Tiago Moreira, Julia Morales-Sanfrutos, Eduard Sabidó, Alexandra M.M. Antunes, Andreia Valente, Ana Preto

Description

Colorectal cancer (CRC) is the second most deadly type of cancer worldwide. Ruthenium compounds have emerged as promising alternatives to classical chemotherapy in the treatment of CRC. The data available here refer the proteomic study performed with the four ruthenium-cyclopentadienyl compounds in colorectal cancer cells.

Anticancer effects of four ruthenium-cyclopentadienyl compounds in colorectal cancer cells: proteomic data

Description

Files

Categories

Licence